Insider Trading activities of Tekla Life Sciences Investors insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tekla Life Sciences Investors since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tekla Life Sciences Investors since year 2005. Table 2 shows the detailed insider transactions of Tekla Life Sciences Investors since 2005. The reporting company's ticker symbol is HQL. The reporting company's CIK number is 884121.
The total value of stock buying since 2005 is $489,891.
The total value of stock sales since 2005 is $26,240.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Tekla Life Sciences Investors (HQL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-01 1,300 $27,348 0 $0 0 $0
2015-06 1,000 $28,170 0 $0 0 $0
2014-06 200 $3,950 0 $0 0 $0
2013-06 6,000 $105,474 0 $0 0 $0
2012-03 1,772 $23,505 0 $0 0 $0
2011-08 10,000 $100,330 0 $0 0 $0
2009-08 3,000 $25,845 0 $0 0 $0
2009-05 1,500 $12,210 0 $0 0 $0
2008-11 2,000 $13,780 0 $0 0 $0
2008-10 2,000 $15,800 0 $0 0 $0
2008-02 1,800 $22,770 0 $0 0 $0
2007-12 0 $0 2,000 $26,240 0 $0
2007-11 1,500 $18,750 0 $0 0 $0
2007-08 1,000 $13,200 0 $0 0 $0
2007-02 3,000 $44,928 0 $0 0 $0
2006-09 2,639 $33,831 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Tekla Life Sciences Investors insiders (HQL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-01-25 Kent Thomas M (Director) Buy 1,300 21.04 27,348
2015-06-29 Stebbins Lucinda H (Director) Buy 1,000 28.17 28,170
2014-06-30 Reardon William S (Director) Buy 200 19.75 3,950
2013-06-04 Omstead Daniel R (President) Buy 6,000 17.58 105,474
2012-03-19 Pohotsky Oleg M (Director) Buy 200 13.30 2,660
2012-03-09 Bonney Michael W (Director) Buy 800 13.26 10,604
2012-03-09 Reardon William S (Director) Buy 772 13.27 10,241
2011-08-08 Omstead Daniel R (President) Buy 10,000 10.03 100,330
2009-08-06 Omstead Daniel R (President) Buy 3,000 8.62 25,845
2009-05-18 Stebbins Lucinda H (Director) Buy 1,500 8.14 12,210
2008-11-26 Omstead Daniel R (President) Buy 2,000 6.89 13,780
2008-10-10 Omstead Daniel R (President) Buy 2,000 7.90 15,800
2008-02-25 Stebbins Lucinda H (Director) Buy 1,800 12.65 22,770
2007-12-31 Stebbins Lucinda H (Director) Sale 2,000 13.12 26,240
2007-11-21 Omstead Daniel R (President) Buy 1,500 12.50 18,750
2007-08-03 Omstead Daniel R (President) Buy 1,000 13.20 13,200
2007-02-09 Stebbins Lucinda H (Director) Buy 3,000 14.98 44,928
2006-09-28 Omstead Daniel R (President) Buy 1,666 12.82 21,358
2006-09-20 Lewin Lawrence S (Director) Buy 973 12.82 12,473

Insider trading activities including stock purchases, stock sales, and option exercises of HQL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tekla Life Sciences Investors (symbol HQL, CIK number 884121) see the Securities and Exchange Commission (SEC) website.